Imaging of Inflammation in Unexplained Cardiomyopathy

Ana Kadkhodayan, Panithaya Chareonthaitawee, Subha V. Raman, Leslie T Jr. Cooper

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Myocarditis is a recognized but underdiagnosed cause of cardiomyopathy due to its wide clinical spectrum and nonspecific presentation. Accurate diagnosis is important because 25% of patients with acute myocarditis develop cardiomyopathy, and of those, approximately 5% per year require heart transplantation or die. Current guidelines for the recognition and treatment of the inflammatory cardiomyopathies are limited. The gold standard for diagnosis, endomyocardial biopsy, has low sensitivity, and thus, multimodality imaging of inflammation plays a crucial role in defining the cardiac abnormalities and in assisting with diagnosis and management. The literature on inflammatory cardiomyopathies is limited to small studies of selected populations due to the diverse etiologies and inherent difficulties in definitive diagnosis. This review focuses on the current and projected use of various imaging modalities, including echocardiography, cardiac magnetic resonance, and nuclear imaging to better define inflammatory cardiomyopathies and aid in their management; it specifically focuses on cardiac sarcoidosis, and giant cell, eosinophilic, and lymphocytic myocarditis.

Original languageEnglish (US)
Pages (from-to)603-617
Number of pages15
JournalJACC: Cardiovascular Imaging
Volume9
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Cardiomyopathies
Inflammation
Myocarditis
Giant Cells
Heart Transplantation
Sarcoidosis
Echocardiography
Magnetic Resonance Imaging
Guidelines
Biopsy
Population
Therapeutics

Keywords

  • cardiac sarcoidosis
  • eosinophilic myocarditis
  • giant cell myocarditis
  • lymphocytic myocarditis
  • myocarditis imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Imaging of Inflammation in Unexplained Cardiomyopathy. / Kadkhodayan, Ana; Chareonthaitawee, Panithaya; Raman, Subha V.; Cooper, Leslie T Jr.

In: JACC: Cardiovascular Imaging, Vol. 9, No. 5, 01.05.2016, p. 603-617.

Research output: Contribution to journalArticle

Kadkhodayan, Ana ; Chareonthaitawee, Panithaya ; Raman, Subha V. ; Cooper, Leslie T Jr. / Imaging of Inflammation in Unexplained Cardiomyopathy. In: JACC: Cardiovascular Imaging. 2016 ; Vol. 9, No. 5. pp. 603-617.
@article{430a496cb6bc4e40a4746b23a9f7cc4f,
title = "Imaging of Inflammation in Unexplained Cardiomyopathy",
abstract = "Myocarditis is a recognized but underdiagnosed cause of cardiomyopathy due to its wide clinical spectrum and nonspecific presentation. Accurate diagnosis is important because 25{\%} of patients with acute myocarditis develop cardiomyopathy, and of those, approximately 5{\%} per year require heart transplantation or die. Current guidelines for the recognition and treatment of the inflammatory cardiomyopathies are limited. The gold standard for diagnosis, endomyocardial biopsy, has low sensitivity, and thus, multimodality imaging of inflammation plays a crucial role in defining the cardiac abnormalities and in assisting with diagnosis and management. The literature on inflammatory cardiomyopathies is limited to small studies of selected populations due to the diverse etiologies and inherent difficulties in definitive diagnosis. This review focuses on the current and projected use of various imaging modalities, including echocardiography, cardiac magnetic resonance, and nuclear imaging to better define inflammatory cardiomyopathies and aid in their management; it specifically focuses on cardiac sarcoidosis, and giant cell, eosinophilic, and lymphocytic myocarditis.",
keywords = "cardiac sarcoidosis, eosinophilic myocarditis, giant cell myocarditis, lymphocytic myocarditis, myocarditis imaging",
author = "Ana Kadkhodayan and Panithaya Chareonthaitawee and Raman, {Subha V.} and Cooper, {Leslie T Jr.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.jcmg.2016.01.010",
language = "English (US)",
volume = "9",
pages = "603--617",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Imaging of Inflammation in Unexplained Cardiomyopathy

AU - Kadkhodayan, Ana

AU - Chareonthaitawee, Panithaya

AU - Raman, Subha V.

AU - Cooper, Leslie T Jr.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Myocarditis is a recognized but underdiagnosed cause of cardiomyopathy due to its wide clinical spectrum and nonspecific presentation. Accurate diagnosis is important because 25% of patients with acute myocarditis develop cardiomyopathy, and of those, approximately 5% per year require heart transplantation or die. Current guidelines for the recognition and treatment of the inflammatory cardiomyopathies are limited. The gold standard for diagnosis, endomyocardial biopsy, has low sensitivity, and thus, multimodality imaging of inflammation plays a crucial role in defining the cardiac abnormalities and in assisting with diagnosis and management. The literature on inflammatory cardiomyopathies is limited to small studies of selected populations due to the diverse etiologies and inherent difficulties in definitive diagnosis. This review focuses on the current and projected use of various imaging modalities, including echocardiography, cardiac magnetic resonance, and nuclear imaging to better define inflammatory cardiomyopathies and aid in their management; it specifically focuses on cardiac sarcoidosis, and giant cell, eosinophilic, and lymphocytic myocarditis.

AB - Myocarditis is a recognized but underdiagnosed cause of cardiomyopathy due to its wide clinical spectrum and nonspecific presentation. Accurate diagnosis is important because 25% of patients with acute myocarditis develop cardiomyopathy, and of those, approximately 5% per year require heart transplantation or die. Current guidelines for the recognition and treatment of the inflammatory cardiomyopathies are limited. The gold standard for diagnosis, endomyocardial biopsy, has low sensitivity, and thus, multimodality imaging of inflammation plays a crucial role in defining the cardiac abnormalities and in assisting with diagnosis and management. The literature on inflammatory cardiomyopathies is limited to small studies of selected populations due to the diverse etiologies and inherent difficulties in definitive diagnosis. This review focuses on the current and projected use of various imaging modalities, including echocardiography, cardiac magnetic resonance, and nuclear imaging to better define inflammatory cardiomyopathies and aid in their management; it specifically focuses on cardiac sarcoidosis, and giant cell, eosinophilic, and lymphocytic myocarditis.

KW - cardiac sarcoidosis

KW - eosinophilic myocarditis

KW - giant cell myocarditis

KW - lymphocytic myocarditis

KW - myocarditis imaging

UR - http://www.scopus.com/inward/record.url?scp=84965122383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965122383&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2016.01.010

DO - 10.1016/j.jcmg.2016.01.010

M3 - Article

VL - 9

SP - 603

EP - 617

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

IS - 5

ER -